The effect of synthetic analogues of chymostatin upon protein degradation in isolated skeletal muscle.
A series of peptides based on the structure of the proteinase inhibitor chymostatin were tested for their toxicity and ability to suppress protein degradation in the isolated mouse diaphragm. The inhibitory activities of the analogues were very similar, in marked contrast to their disparate abilities as inhibitors of chymotrypsin. Toxicity was determined by measurement of the rates of protein synthesis and of leakage of lactate dehydrogenase into the incubation medium. No significant toxicity was measurable at concentrations of inhibitor that were effective at suppressing proteolysis. The structural features of the chymostatin molecule may be less than optimal for suppression of proteolysis in muscle.
D000818:Animals; D002918:Chymotrypsin / Q000494:pharmacology; D005260:Female; D006868:Hydrolysis; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D051379:Mice; D009124:Muscle Proteins / Q000096:biosynthesis / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology
D007328:Insulin; D009124:Muscle Proteins; D009842:Oligopeptides; C002101:chymostatin; D007770:L-Lactate Dehydrogenase; D002918:Chymotrypsin